nanoparticle DECT contrast agent (Duke University)

N/A

Report date: 2025/03/20 14:56:50

Base Information

Drug Namenanoparticle DECT contrast agent (Duke University)
Drug Alias NameN/A
ClassificationDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationAtherosclerosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDuke University
China Registration ClassN/A

Develop Information

Active CompaniesDuke University
Inactive CompaniesN/A
Active IndicationsInflammationAtherosclerosisNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A